TCF1-positive and TCF1-negative TRM CD8 T cell subsets and cDC1s orchestrate melanoma protection and immunotherapy response
Background Melanoma, the most lethal form of skin cancer, has undergone a transformative treatment shift with the advent of checkpoint blockade immunotherapy (CBI). Understanding the intricate network of immune cells infiltrating the tumor and orchestrating the control of melanoma cells and the resp...
Saved in:
Main Authors: | Saraí G De León-Rodríguez, Cristina Aguilar-Flores, Julián A Gajón, Ángel Juárez-Flores, Alejandra Mantilla, Raquel Gerson-Cwilich, José Fabián Martínez-Herrera, Diana Alejandra Villegas-Osorno, Claudia T Gutiérrez-Quiroz, Sergio Buenaventura-Cisneros, Mario Alberto Sánchez-Prieto, Edmundo Castelán-Maldonado, Samuel Rivera Rivera, Ezequiel M Fuentes-Pananá, Laura C Bonifaz |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-07-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/12/7/e008739.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transcription factor TCF4: structure, function, and associated diseases
by: R. R. Savchenko, et al.
Published: (2024-11-01) -
LRP11 promotes stem-like T cells via MAPK13-mediated TCF1 phosphorylation, enhancing anti-PD1 immunotherapy
by: Zhishui Chen, et al.
Published: (2024-01-01) -
TCF7L2 gene polymorphism in populations of f ive Siberian ethnic groups
by: L. E. Tabikhanova, et al.
Published: (2022-04-01) -
Association between TCF7L2 Genotype and Glycemic Control in Diabetic Patients Treated with Gliclazide
by: Martin Javorský, et al.
Published: (2013-01-01) -
Corrigendum to “MicroRNA-30-5p Suppresses Inflammatory Factor-Induced Endothelial Cell Injury by Targeting TCF21”
by: Zhenyu Zhou, et al.
Published: (2021-01-01)